190 related articles for article (PubMed ID: 34699578)
1. A rapid, simple and sensitive LC-MS/MS method for lenvatinib quantification in human plasma for therapeutic drug monitoring.
Zanchetta M; Iacuzzi V; Posocco B; Bortolin G; Poetto AS; Orleni M; Canil G; Guardascione M; Foltran L; Fanotto V; Puglisi F; Gagno S; Toffoli G
PLoS One; 2021; 16(10):e0259137. PubMed ID: 34699578
[TBL] [Abstract][Full Text] [Related]
2. A fast and validated LC-MS/MS method to quantify lenvatinib in dried blood spot.
Zanchetta M; Posocco B; Gagno S; Poetto AS; Orleni M; Canil G; Guardascione M; Puglisi F; Toffoli G
J Pharm Biomed Anal; 2023 Mar; 226():115255. PubMed ID: 36682207
[TBL] [Abstract][Full Text] [Related]
3. A LC-MS/MS method for therapeutic drug monitoring of sorafenib, regorafenib and their active metabolites in patients with hepatocellular carcinoma.
Iacuzzi V; Zanchetta M; Gagno S; Poetto AS; Orleni M; Marangon E; Guardascione M; Foltran L; Posocco B; Toffoli G
J Pharm Biomed Anal; 2020 Aug; 187():113358. PubMed ID: 32460216
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous determination of 11 oral targeted antineoplastic drugs and 2 active metabolites by LC-MS/MS in human plasma and its application to therapeutic drug monitoring in cancer patients.
Zhao J; Yan D; Li Y; Xu X; Li F; Zhang S; Jin J; Qiu F
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Apr; 1237():124100. PubMed ID: 38547701
[TBL] [Abstract][Full Text] [Related]
5. A new dried blood spot LC-MS/MS method for therapeutic drug monitoring of palbociclib, ribociclib, and letrozole in patients with cancer.
Poetto AS; Posocco B; Gagno S; Orleni M; Zanchetta M; Iacuzzi V; Canil G; Buzzo M; Montico M; Guardascione M; Basile D; Pelizzari G; Alberti M; Gerratana L; Puglisi F; Toffoli G
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Nov; 1185():122985. PubMed ID: 34700133
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a rapid LC-MS/MS method to quantify letrozole in human plasma and its application to therapeutic drug monitoring.
Shao R; Yu LY; Lou HG; Ruan ZR; Jiang B; Chen JL
Biomed Chromatogr; 2016 Apr; 30(4):632-7. PubMed ID: 26317321
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous Quantification of Nine Antimicrobials by LC-MS/MS for Therapeutic Drug Monitoring in Critically Ill Patients.
Neugebauer S; Wichmann C; Bremer-Streck S; Hagel S; Kiehntopf M
Ther Drug Monit; 2019 Feb; 41(1):29-37. PubMed ID: 30320624
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry.
Haouala A; Zanolari B; Rochat B; Montemurro M; Zaman K; Duchosal MA; Ris HB; Leyvraz S; Widmer N; Decosterd LA
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(22):1982-96. PubMed ID: 19505856
[TBL] [Abstract][Full Text] [Related]
9. A validated LC-MS/MS method of total and unbound lenvatinib quantification in human serum for protein binding studies by equilibrium dialysis.
Mano Y; Kusano K
J Pharm Biomed Anal; 2015 Oct; 114():82-7. PubMed ID: 26026266
[TBL] [Abstract][Full Text] [Related]
10. A semi-automated LC-MS/MS method for the determination of LCI699, a steroid 11β-hydroxylase inhibitor, in human plasma.
Li W; Luo S; Rebello S; Flarakos J; Tse FL
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jun; 960():182-93. PubMed ID: 24814004
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a sensitive liquid chromatography tandem mass spectrometry assay for the simultaneous determination of ten kinase inhibitors in human serum and plasma.
Aghai F; Zimmermann S; Kurlbaum M; Jung P; Pelzer T; Klinker H; Isberner N; Scherf-Clavel O
Anal Bioanal Chem; 2021 Jan; 413(2):599-612. PubMed ID: 33155133
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a simple, fast, and sensitive LC/MS/MS method for the quantification of oxfendazole in human plasma and its application to clinical pharmacokinetic study.
Bach T; Bae S; D'Cunha R; Winokur P; An G
J Pharm Biomed Anal; 2019 Jul; 171():111-117. PubMed ID: 30981954
[TBL] [Abstract][Full Text] [Related]
13. Quantification of sorafenib, lenvatinib, and apatinib in human plasma for therapeutic drug monitoring by UPLC-MS/MS.
Ye Z; Wu L; Zhang X; Hu Y; Zheng L
J Pharm Biomed Anal; 2021 Aug; 202():114161. PubMed ID: 34052550
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of High-Throughput Bioanalytical Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method for the Quantification of Newly Synthesized Antitumor Carbonic Anhydrase Inhibitors in Human Plasma.
Abdel-Megied AM; Eldehna WM; Abdelrahman MA; Elbarbry FA
Molecules; 2020 Dec; 25(23):. PubMed ID: 33291270
[TBL] [Abstract][Full Text] [Related]
15. Reliable and Easy-To-Use Liquid Chromatography-Tandem Mass Spectrometry Assay for Quantification of Olorofim (F901318), a Novel Antifungal Drug, in Human Plasma and Serum.
Müller C; Fietz C; Koehler P; Sibley G; Nforbugwe ACA; Streichert T; Wiesen MHJ
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30150474
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of an LC-MS/MS method with a broad linear dynamic range for the quantification of tivozanib in human and mouse plasma, mouse tissue homogenates, and culture medium.
Bruin MAC; Rosing H; Lucas L; Wang J; Huitema ADR; Schinkel AH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Sep; 1125():121723. PubMed ID: 31352204
[TBL] [Abstract][Full Text] [Related]
17. High-Performance Liquid Chromatography for Therapeutic Drug Monitoring of Serum Lenvatinib.
Watanabe Y; Doki K; Sekine I; Hara H; Homma M
Ther Drug Monit; 2020 Aug; 42(4):554-558. PubMed ID: 32398418
[TBL] [Abstract][Full Text] [Related]
18. Quantitation of 10 antibiotics in plasma: Sulfosalicylic acid combined with 2D-LC-MS/MS is a robust assay for beta-lactam therapeutic drug monitoring.
Palayer M; Chaussenery-Lorentz O; Boubekeur L; Urbina T; Maury E; Maubert MA; Pilon A; Bourgogne E
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Apr; 1221():123685. PubMed ID: 37023569
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous and rapid determination of 12 tyrosine kinase inhibitors by LC-MS/MS in human plasma: Application to therapeutic drug monitoring in patients with non-small cell lung cancer.
Zhou L; Wang S; Chen M; Huang S; Zhang M; Bao W; Bao A; Zhang P; Guo H; Liu Z; Xie G; Gao J; Wu Z; Lou Y; Fan G
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jun; 1175():122752. PubMed ID: 33991955
[TBL] [Abstract][Full Text] [Related]
20. Validation of an LC-MS/MS assay for rapid and simultaneous quantification of 21 kinase inhibitors in human plasma and serum for therapeutic drug monitoring.
Al Shirity ZN; Westra N; Hateren KV; Munnink THO; Kosterink JGW; Mian P; Hooge MNL; Touw DJ; Gareb B
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Sep; 1229():123872. PubMed ID: 37716342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
